Invention Grant
US07897641B2 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
失效
用于预防和/或治疗由使用免疫抑制剂诱导的细胞毒性作用的组合物
- Patent Title: Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
- Patent Title (中): 用于预防和/或治疗由使用免疫抑制剂诱导的细胞毒性作用的组合物
-
Application No.: US10220185Application Date: 2001-02-20
-
Publication No.: US07897641B2Publication Date: 2011-03-01
- Inventor: Claudio Cavazza
- Applicant: Claudio Cavazza
- Applicant Address: IT Rome
- Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee Address: IT Rome
- Agency: Lucas & Mercanti, LLP
- Priority: ITRM2000A0107 20000302
- International Application: PCT/IT01/00082 WO 20010220
- International Announcement: WO01/64204 WO 20010907
- Main IPC: A01N37/12
- IPC: A01N37/12 ; A01N37/30 ; A01N37/02
Abstract:
A composition is disclosed which is suitable for the prevention and/or treatment of cell and tissue abnormalities of exogenous, toxic or metabolic origin and suitable for reducing the toxic effects of cyclosporin-A and other immunosuppressive agents, which may take the form of a food supplement or of an actual medicine, containing as its active ingredients in combination or separately packaged: (a) propionyl L-carnitine or one of its pharmacologically acceptable salts, and (b) an amino acid selected from the group consisting of glycine, serine, alanine and arginine, or mixtures thereof.
Public/Granted literature
Information query
IPC分类:
